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ABSTRACT
Background: Cancer is the second leading cause of death in the United States and
remains a major public health problem worldwide. Epidemiological studies have
demonstrated that insulin like growth factor-1 (IGF-1) is linked to ulcers and most
cancers. Although studies have investigated the role of IGF1 in ulcer healing and cancer
pathogenesis, the link between ulcer and cancer remains unclear. Hence, we assessed
the relationship between ulcers and cancers.
Methods: This study consists of a sample of 180 cancer patients obtain by convenience
sampling who were seen at Nebraska Medicine and were enrolled in the integrated
cancer repository for cancer research (iCaRe2) database. Demographics and
socioeconomic data were described using descriptive statistics and data were analyzed
using Linear regression and TTEST.
Results: The result of this study showed no association between ulcer diagnosis and
age of cancer diagnosis. Although patients with gastroduodenal ulcer seem to be
diagnosed of cancer later compared to non-gastroduodenal patients, this finding was
however not significant.
Discussion: Research on the association between ulcers and cancer is scarce. This
study is significant in that it will serve as a landmark for future research which may lead
to establishing the link between ulcers and cancers and thus, predict or prevent certain
cancer types.
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INTRODUCTION
BACKGROUND
Cancer is a major public health problem worldwide and it’s the second leading cause of
death in the United States (Heron, Anderson & Brief, 2016). In the United States, it is
estimated that about 1,762,450 new cases of cancer and 606,880 deaths would occur in
2019 (Siegel, Miller & Jemal, 2019). This study focuses on head and neck,
gastrointestinal, and pancreatic cancer. Head and neck cancer include neoplasm of the
oral cavity, pharynx and larynx. Head and neck cancer rank sixth among the most
common cancers, accounting for approximately 6% of all cancer cases, and more than
630,000 new cases of head and neck cancer are diagnosed worldwide each year
(Vigneswaran, Williams, 2014). In the United States, it is estimated that 65,410 people
(48,000 men and 17,410 women) will develop head and neck cancer in 2019 and
14,620 would die from it (10,980 men and 3,640 women) (American society of clinical
oncology, 2019). Although the risk of head and neck cancer is strongly associated with
smoking and alcohol consumption, epidemiological data has linked elevated levels of
IGF1 and head and neck cancers (Slomiany et al., 2006)
Gastrointestinal cancers are cancers involving the digestive tract. These include
cancer of the esophagus, stomach, colon, rectum and pancreas (Herszenyi, Tulassay,
2010). The most common sites of GI cancer are the colon and rectum which represent
over 50% of GI cancers and accounts for the fourth most common cancer type in the
United States. It is estimated that about 145,600 new cases of colorectal cancer and
over 51,000 deaths would occur in 2019 (SEER, 2019a) Gastric cancers account for the
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second most common gastrointestinal cancer and despite its decline in incidence and
mortality, has remained one of the leading cause of cancer related death worldwide
(Brenner, Rothenbacher & Arndt, 2009).An estimated 97,915 people currently living with
gastric cancer in the United States with this cancer account for about 1.8% of all cancer
death and represent 1.6% of all new cancer cases in the United States. Surveillance
epidemiology and end results program (SEER), which is an authoritative source for
cancer statistics in the United States estimated that about 27,510 new cases of stomach
cancer will occur, resulting in 11,140 deaths (SEER, 2016). The strongest established
risk factor for gastric cancer is helicobacter pylori infection (Wroblewski, Peek & Wilson,
2010). Other identified risk factors are smoking, family history of gastric cancer, alcohol
intake, and dietary factors (Brenner, Rothenbacher & Arndt, 2009). There is a similarity
in risk factors of gastrointestinal and pancreatic cancers. Pancreatic cancer is a leading
cause of cancer mortality and remains one of the most fatal neoplasms in the world (Ilic,
Ilic, 2016). It is the third most common cancer causing death in the USA and the
seventh leading cause of global cancer death (Karimi et al., 2019) .There are two main
types of pancreatic cancer: adenocarcinoma that makes up about 85% of cases and
pancreatic endocrine tumor that accounts for about 5% of cases (Ilic, Ilic, 2016). Based
on American cancer society estimates, pancreatic cancer would account for 56,770 new
cases and would cause 45,750 deaths in 2019 (American cancer society, 2019a)
.Although some risk factors have been shown to be associated with pancreatic cancer,
the exact cause of pancreatic cancer still remains unknown. Identified risk factors
include smoking, diabetes, obesity, alcohol consumption, pancreatitis, physical
inactivity, dietary factors, family history, genetics, increased IGF1 and helicobacter
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pylori infection (Aier et al., 2019) The prognosis of pancreatic cancer is quite poor with
an estimated overall 5 year survival rate of 8.2% (Karimi et al., 2019). Despite the
improved understanding of the epidemiology pancreatic cancer it has remained a major
public health issue with one of the lowest survival rates.
There is epidemiological evidence that insulin like growth factor 1 (IGF1), which is
known to modulate cell growth and survival, is linked to an increased risk of certain
cancers, particularly pancreatic, gastrointestinal, and head and neck cancers (Ii et al.,
2011, Barnes et al., 2007, Karczewski et al., 2019). The role of IGF1 in the
pathogenesis and healing of ulcer is also well known. Gastric ulceration activates
expression of several growth factors including IGF-1 which accelerates gastric healing
by promoting cell re-epithelization, proliferation and cox-2 expression (Nguyen et al.,
2007, Howarth, 2003). More recently evidence has accrued to demonstrate that IGFs
play an important role in the metastasis and spread of many cancers. The IGF-1
receptor is commonly over expressed in many cancers including head and neck
cancers (HNC), as well as gastric and pancreatic cancer. Studies have identified
pathways emanating from IGF-1 receptor that activates multiple signaling pathways
which then result in cancer cell proliferation, differentiation, transformation, adhesion,
and tumorigenicity (Pollak, 2008, LeRoith, Roberts Jr, 2003). Although several studies
have investigated the role of IGF in ulcer healing and cancer pathogenesis
independently, the link between ulcer and cancer remain unclear. This study aims to
address this gap as well as explore the relationship between ulcer diagnosis and age of
diagnosis of gastrointestinal, pancreatic and HN cancer.
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AIMS
AIM 1: The main aim of this study is to investigate the relationship between ulcer
diagnosis and age of head and neck, gastrointestinal and pancreatic cancer diagnosis.
HYPOTHESIS
Null hypothesis: There is no difference in the timeline of diagnosis between cancer
patients with ulcers and cancer patients without ulcers.
Alternative Hypothesis: Patients with ulcers are diagnosed sooner or later of cancers
compared to patients without ulcers.
MATERIALS AND METHODS:
Data source and study population
Data from the integrated cancer repository for cancer research (iCaRe 2) database was
used to conduct this study. (iCaRe2) is a multi-institutional bio specimen registry and
resource created and maintained by the Fred and Pamela Buffet cancer center to
collect and manage standardized, multi-dimensional, longitudinal data and bio specimen
on consented adult cancer patient, high risk individuals and normal controls (ICARe2,
2019). ICaRe2 aims to enable comprehensive study of risk factors of cancer
development and disease progression as well as enable strategies for prevention, early
detection and treatment of cancer (ICARe2, 2019). This database is a convenience
sampling and includes data on quality of life, disease specific parameters, medications,
treatment, surgical history, survival/outcome, socio-demographics characteristics, health
behaviors, and anthropometric measures. This case control study consists of a sample
6

of 960 cancer patients who were seen at Nebraska medicine and enrolled in any three
of the iCaRe2 cancer registry; pancreatic cancer collaborative registry (PCCR),
gastrointestinal and abdominal collaborative registry (GA CARE), and, head and neck
cancer registry (HN CARE). ICaRe2 data contains identifiers hence; this study required
approval from an institutional review board and was approved by UNMC IRB. (IRB #
204-19-EP)
Eligibility Criteria
Eligibility criteria for this study included adult patients above the age of 19, with a life
time diagnosis of cancer, who enrolled and provided consent in UNMC GACARE,
PCCR, and HN CARE registry of the iCaRe2 database from January 1 2003 to March 1
2019 and having a diagnosis of head and neck, gastrointestinal or pancreatic cancer
and an available survey data. Subjects under the age of 19 were excluded, vulnerable
subjects including pregnant women, prisoners, decisionally impaired persons and
educationally disadvantaged individuals were excluded. Participants who had no data
on age of pancreatic, HN and gastrointestinal cancer diagnosis were excluded.
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Figure 1. A flow diagram of Eligibility participants.

Enrollment (IcaRe2 January 1 2003 to
March 1 2019, all cancer registries.
n=27,176)
Non UNMC centers
(n=10,659)
UNMC IcaRe2 (n=16,517)
Deceased
(n=10,140)
Consented living
participants (n=6,377)
Non PCCR, GACCARE,
HNCARE (n=5,233)
Patients from PCCR, GACCARE,
HNCARE registry (n= 1,444)
Subjects who didn’t fill out
questionnaire (n=184)
Participants who met initial
eligibility (n=960)
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Participant who met initially eligibility (UNMC ICaRe2
January 1 2003 to March 1 2019, n=960).
PCCR=522
HNCARE=100
GACCARE=338

Patients without Ulcer
(n=915)

Randomly selected 135 controls
without gastroduodenal ulcer
from each cancer registry
(n=135, 14.06%)
PCCR=87
HNCARE=15
GACCARE=33

Patients with
gastroduodenal ulcer and
cancer (n=45, 4.68%)
PCCR=29
HNCARE=5
GACCARE=11

Total patients
excluded (n=780,
81.25%)

Total patients included in the study (n=180, 18.75%)

NOTE:
PCCR: Pancreas care registry
HNCARE: Head and neck care registry
GACCARE: Gastrointestinal and abdominal care registry
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STUDY VARIABLES
Ulcer
A diagnosis of ulcer was based on patient self-report as described in the iCaRe2 core
data dictionary and questionnaire. Specifically, in iCaRe2, the diagnosis of ulcer was
based on the following sequential questions: History of peptic or stomach ulcer?
Cancer
Diagnosis of the various cancer type used in this project was based on patient’s medical
data. Specifically, the diagnosis of patients with gastrointestinal cancer in the
GACCARE registry was based on upper GI endoscopy and biopsy, laparoscopy, CT,
and MRI. Diagnosis of pancreatic, and head and neck cancer was by biopsy of the
tumor. Age at which cancer was diagnosed was also extracted from the patients
medical data.
Socio-demographic variables
Age, sex, race/ethnicity, and income were collected using administered questionnaire
from iCaRe2 database. Race/ethnicity was reported on the questionnaire as White,
Black/African American, Asian, American Indian or Alaska native, native Hawaiian/other
pacific island, and Hispanic or Latino. Income level was categorized in to 7 groups (less
than $10,000, $10,000-24,999, $25,000-44,999, $45,000-74,999, $75,000-100,000,
greater than $100,000, refused)
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Behavioral factors
Smoking history and alcohol consumption status were extracted from iCaRe 2
administered questionnaires and was based on the following questions; have you ever
smoked cigarettes in your life, how many cigarettes did you smoke per day, how many
years did you smoke in total, cigarette stop age, do you currently drink alcohol, Alcohol
start age, what was you heaviest use of alcohol?
Body mass index
Body mass index (expressed in meter square) was extracted from the medical history.
According to CDC BMI classification, (<18.50 kg/m2) is underweight, (18.50-24.99
kg/m2) is considered normal; (25.00-29.99 kg/m2) is classified as overweight, and above
30 kg/m2 obese (CDC, 2017).
STATISTICAL ANALYSIS
Duplicate data were removed and missing data excluded. All three cancer registries
were merged by case id and 45 controls were randomly selected and merged to 45
cases bringing the total sample size to 90 patients. The independent variable was ulcer
and was treated as a binary variable; the dependent variable was age at cancer
diagnosis and treated as a continuous variable. Descriptive statistics (percentage,
frequencies, mean, medians and standard deviation) were used to describe the
socioeconomic and demographic variables for head and neck, gastrointestinal and
pancreas cancer. Each patient age of cancer diagnosis was compared with the median
age of same primary cancer diagnosis of our study population and the U.S population
after adjusting the age for both sample population. The adjusted mean age of cancer
11

diagnosis for gastroduodenal ulcer patients was then compared to the adjusted mean
age of cancer diagnosis for patient without gastroduodenal ulcer in both the U.S
population and iCaRe2 sample using a TTEST. Linear regression was also used to
analyze the relationship between the adjusted mean age of cancer diagnosis for iCaRe2
and U.S population. The analysis was conducted with SAS statistical software version
9.4, (SAS Inc., Cary, NC USA).
FOUNDATIONAL AND CONCENTRATION COMPETENCY
EPIMPH2

Apply appropriate study design and data collection methods to answer

specific epidemiologic questions and address public health issues.Data would be
requested and collected from iCaRe2, and a case control study would be designed to
address public health problems of several cancer types
EPIMPH3

Analyze datasets using computer software. Data collected from UNMC

iCaRe2 will be analyzed using sas software.
MPHF21

Perform effectively on interprofessional team. An open channel of

communication will be maintained with capstone committee members throughout the
course of the project to ensure a satisfactory project.
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RESULTS
Table 1 Characteristics of study participants by ulcer status, (n=180)
Participant’s characteristics

Gastroduodenal
Ulcer

No gastroduodenal
Ulcer

Overall

Total

No (%).
45 (25)

No (%).
135 (75)

No (%).
180 (100)

Cancer diagnosis age, years a
Enrolment age, years a

65 (13.7)
66 (13.4)

63 (11.0)
64 (11.1)

63 (12.4)
65 (12.2)

Gender
Female
Male

20 (44.4)
25 (55.6)

64 (47.4)
71 (52.6)

84 (46.7)
96 (53.3)

BMI b
Underweight
Normal
Overweight
Obese
Missing

2 (4.8)
14 (33.3)
15 (35.7)
11 (26.2)
3

1 (1.1)
20 (22.5)
28 (31.5)
40 (44.9)
46

3 (2.3)
34 (26.0)
43 (32.8)
51 (38.9)
49

Cancer registry
GACCARE
HNCARE
PCCR

11 (24.4)
5 (11.1)
29 (64.5)

33(24.4)
15 (11.1)
87 (64.5)

44 (24.4)
20 (11.1)
116 (64.5)

Smoking c
Never Smokers
Ever Smokers
Missing
Refuse d

10 (24.4)
31 (75.6)
4
0

39 (43.3)
51 (56.7)
44
1

49 (37.4)
82 (62.6)
48
1

Alcohol intake d, e
< 1 drink/month
>1 drink /month
Total years of intake e
Refuse
Missing

12 (27.9)
31 (72.1)
42.9 (13.4)
1
1

24 (26.4)
67 (73.6)
42.8 (12.5)
9
35

36 (26.9)
98 (73.1)
42.9 (13.0)
10
36

Race
American Indian
Asian
African American
White
Unknown

1 (2.2)
0
3 (6.7)
41 (91.1)
0

1 (0.7)
3 (2.3)
5 (3.8)
124 (93.2)
2

2 (1.1)
3 (1.7)
8 (4.5)
165 (92.7)
2

P valuee

0.4
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Participants characteristics

Income
< $10,000
$10,000 - $24,999
$25,000-$44,999
$45,000-$74,999
$75,000-$100,000
$>100,000
Refused
Missing

Gastroduodenal
Ulcer

No gastroduodenal
Ulcer

Overall

No (%).

No (%).

No (%).

3 (19.0)
4 (25.0)
4 (25.0)
2 (12.5)
1 (6.25)
2 (12.5)
1
28

0
4 (14.8)
7 (25.9)
5 (18.5)
4 (14.8)
7 (25.9)
3
105

3 (7.0)
8 (18.6)
11 (25.6)
7 (16.3)
5 (11.6)
9 (20.9)
4
133

P-value

Notes.
a, eAge and total year of alcohol intake was presented as mean ± standard deviation, and other data were expressed as
frequency (weighted %).
b body mass index (BMI) <18.5kg/m2 was defined as underweight, BMI between 18.5 and 24.9kg/m2 considered as normal,
BMI between 25 and 29.9kg/m2 as overweight and BMI ≥ 30kg/m2 as obese.
c smoking status was defined base of on participant who had smoked more than 100 cigarettes.
d one drink was considered as one shot of liquor, a mixed drink, one glass of wine or one 12 ounce of beer per month during a
12 month period or more than 20 drinks in a lifetime.
e From 2 sample two test.

Table 1 shows the general characteristic of participant in the study by gastroduodenal
ulcer status. Among the 180 included study participants, 45 participants had
gastroduodenal ulcer and 135 participants do not have gastroduodenal ulcer. The mean
enrolment age of cancer patient with gastroduodenal ulcer was 66 years and 64 years
for participants without gastroduodenal ulcer. Participants without gastroduodenal ulcer
seem to be more obese (44.9) than participant with gastroduodenal ulcer (26.2). There
was no difference in the mean total years of alcohol intake by gastroduodenal ulcer
status. Lastly 92 percent of participants in the study were white and 22.6 percent earned
less than $25,000 annual income.
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Table 2 Characteristics of study participants by cancer registry, (n=180)

Total

GACCAREe
No (%).
44

HNCAREf
No (%).
20

PCCRg
No (%).
116

Ulcer
No
Yes

33 (75)
11 (25)

15 (75)
5 (25)

87 (75)
29 (15)

Age, years a

59.9 ± 12.3

60.9 ± 13.9

64.8 ± 10.8

Gender
Female
Male

27 (61.4)
17 (38.6)

5 (25)
15 (75)

52 (45)
64 (55)

BMI b
Underweight
Normal
Overweight
Obese
Missing

1 (4.2)
8 (33.3)
6 (25.0)
9 (37.5)
20

1 (6.7)
8 (53.3)
4 (26.7)
2 (13.3)
5

1 (1.1)
18 (19.6)
33 (35.9)
40 (43.5)
24

Smoking c
Never Smokers
Ever Smokers
Missing
Refuse

10 (38.5)
14 (61.5)
30
0

3 (20.0)
12 (80.0)
5
0

36 (39.1)
56 (60.9)
23
1

Alcohol intake d, e
< 1 drink/month
>1 drink /month
Total years of intake
Refuse d
Missing

5 (20.8)
19 (79.2)
39.77 (12.7)
0 (0)
25

0 (0)
15 (100)
43.71 (15.4)
0 (0)
5

31(32.6)
64 (67.4)
44 (11.9)
10
11

Race
American Indian
Asian
African American
White
Unknown

1 (2.3)
1 (2.3)
4 (9.0)
38 (86.4)
0 (0)

0 (0)
0 (0)
0 (0)
19 (100)
1

1(0.9)
2(1.7)
4 (3.5)
108(93.9)
1

Participants characteristics
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Table 2. Continue. Characteristics of study participants by cancer registry, (n=180)

Total

GACCAREe
No (%).
44

HNCAREf
No (%).
20

PCCRg
No (%).
116

Income
< $10,000
$10,000 - $24,999
$25,000-$44,999
$45,000-$74,999
$75,000-$100,000
$>100,000
Refused
Missing

3 (13.6)
3 (13.6)
6 (27.3)
3 (13.6)
2 (9.1)
5 (22.7)
1
21

0 (0)
4 (28.6)
4 (28.6)
2 (14.3)
2 (14.3)
2 (14.3)
2 (12.50)
4

0 (0)
1(14.3)
1 (14.3)
2 (28.6)
1 (14.3)
2 (28.6)
1 (25.00)
108

Participants characteristics

Notes.
e Gaccare gastrointestinal and abdominal cancer care registry
f Hncare head and neck cancer care registry
g PCCR pancreas cancer care registry
a, eAge and total year of alcohol intake was presented as mean ± standard deviation, and other data were expressed as
frequency (weighted %).
b body mass index (BMI) <18.5kg/m2 was defined as underweight, BMI between 18.5 and 24.9kg/m2 considered as normal,
BMI between 25 and 29.9kg/m2 as overweight and BMI ≥ 30kg/m2 as obese.
c smoking status was defined base of on participant who had smoked more than 100 cigarettes.
d one drink was considered as one shot of liquor, a mixed drink, one glass of wine or one 12 ounce of beer per month during a
12 month period or more than 20 drinks in a lifetime.

Table 2 shows the general characteristics of participants in the study by cancer registry.
Among the 180 included study participants, 44 were from gastrointestinal and
abdominal cancer collaborative registry, 20 were from head and neck cancer registry
and 116 participants were from pancreas cancer registry. The mean age diagnosis of
participants with pancreas cancer (64.8 ± 10.8) was higher than the age diagnosis of
participants with head and neck cancer (60.9 ± 13.9) and gastrointestinal cancer (59.9 ±
12.3). Among the patients studied for the various cancer types, patients with pancreas
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cancer seemed to be more overweight and obese than patients with head and neck and
gastrointestinal and abdominal cancer. Relative to participants from gastrointestinal
and abdominal and pancreas cancer registry, participants with head and neck cancer
had a higher proportion of males (75.00 %) versus 55 % for pancreas cancer and 39.6
% for gastrointestinal and abdominal cancer patients. Participants seemed to have at
least one drink per month and a mean total year of alcohol intake of 44 years for head
and neck and pancreas cancer and 39.8 years gastrointestinal and abdominal cancer.
Alcohol intake was higher among patients with head and neck cancer (100 %) and
gastrointestinal cancers (79.1 %) and lower (67.4 %) for pancreas cancer. This finding
was similar to the smoking status, where 80% of head and neck cancer patient, 60.9%
of pancreas cancer patient and 61.5% of patients with gastrointestinal cancer had
smoke at least hundred cigarettes.
Lastly, a major proportion of participants in the study were white with Head and neck
cancer (100%), pancreas cancer (93.9%) and gastrointestinal cancers (86.4%).
Furthermore, 57.2% of patient diagnosed with head and neck cancer earned less than
$45,000 income while 28.6% of pancreas cancer patient earned lower than $45,000.
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Table 3: Median age at cancer diagnosis based on primary cancer type.

Cancer registry

PCCRa
GACCAREb

HNCAREc

Total

Primary
cancer type

Median
age at
diagnosis
of U.S
sample

Median
Gastroduodenal
age at
Ulcer
diagnosis
of iCaRe2
sample

No
Gastroduodenal
Ulcer

n

age
median

n

age
median

Pancreas
Cancer
Colon Cancer
Female

70.00

63.83

29

68.15

87

63.67

72.00

62.03

6

66.21

15

57.00

Colon Cancer
Male

68.00

63.00

2

68.00

13

61.77

Rectal Cancer

63.00

50.82

2

63.66

4

50.02

Gastric
Cancer
Lip and Oral
Cavity Cancer
Laryngeal
Cancer
Salivary Gland
Cancer
Oropharyngeal
Cancer

68.00

54.98

1

40.96

1

69.00

69.00

61.11

4

63.89

9

61.11

65.00

78.52

-

-

2

78.52

64.00

37.43

1

27.73

1

47.13

63.00

58.66

-

-

3

58.66

66.70

64.47

45

51.96

135

63.29

Notes.
Data for U.S median age of cancer diagnosis for lip and oral cavity, oropharyngeal, laryngeal, gastric, and pancreas are
from SEER (SEER, 2019b). Data for U.S median age of cancer diagnosis colon, rectal and salivary gland cancer are from
American cancer society (American cancer society, 2019b)

a PCCR pancreas cancer care registry
b Gaccare gastrointestinal and abdominal cancer care registry
c Hncare head and neck cancer care registry
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Table 3 shows the number of cases per primary cancer type, the median age at
diagnosis of each primary cancer type for gastroduodenal ulcer patients and patients
without gastroduodenal ulcer in our study population and the United States population.
There is a distinction in the median age of diagnosis of colon cancer by gender and this
difference is not seen in other primary cancer types. Pancreas cancer had the highest
number of cases in our sample (116 cases). Gastric, laryngeal and salivary gland
cancer shared the least number of cases in our sample population (2 cases). Also the
median age of diagnosis for colon, oropharyngeal, pancreas, rectal, salivary gland and
gastric cancer in iCaRe2 sample population were lower compared to the United States
population.

Table 4. Association between gastroduodenal ulcers and age cancer diagnosis.
P-Value1

Gastroduodenal
Ulcer

No
gastroduodenal
ulcer

Reference
population

Mean cancer age
difference (SD)

Mean cancer age
difference (SD)

U.S 2

-5.2 (13.4)

-6.8 (11.1)

0.4

iCaRe2

3.8 (12.4)

-0.2 (10.6)

0.2

NOTE:
1 From 2 sample t-test
2 Data for reference U.S mean age of cancer diagnosis for lip and oral cavity, oropharyngeal, laryngeal, gastric, and
pancreas are from SEER (SEER, 2019b). Data for reference U.S mean age of cancer diagnosis for colon, rectal and
salivary gland cancer are from American cancer society (American cancer society, 2019b)
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µ (ulcer) =

∑ (normalize cancer diagnosis age for ulcer patient)
Number of ulcer cases

µ (no ulcer) =

∑ (normalize cancer diagnosis age for non-ulcer patient)
Number of non-ulcer cases

Table 4 shows the association between gastroduodenal ulcers and age cancer
diagnosis using a 2 sample t test. Patients with no ulcer seemed to have lower mean
age of cancer diagnosis for both U.S (-6.8) and iCaRe2 (-0.2) compare to patients with
gastroduodenal ulcer U.S (-5.2) and iCaRe2 (3.8).

Table 5. Model of association between gastroduodenal ulcer and cancers iCaRe2 .
Variables

Beta
Coefficient

Standard
Error

P value

Enrollment age

0.9

0.0

<0.0

Gastroduodenal
ulcer

1.2

0.7

0.1

Linear regression model: Adjusted Age of cancer diagnosis (iCaRe2 sample) =
gastroduodenal ulcer (yes/no) + enrollment age.
The result suggest after adjusting for age of enrollment , the age of cancer diagnosis for
patients with gastroduodenal ulcer is 1.2 year greater than patients with cancer who do
not have gastroduodenal ulcer however this is not significant p value (0.1) .
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Table 6. Model of association between gastroduodenal ulcer and cancers U.S.
Variables

Beta
Coefficient

Standard
Error

P value

Enrollment age

0.96

0.02

<0.00

Gastroduodenal
ulcer

-0.03

0.49

0.95

Linear regression model: Adjusted Age of cancer diagnosis (U.S sample)=
gastroduodenal ulcer (yes/no) + enrollment age.
The result suggest after adjusting for age of enrollment , the age of cancer diagnosis for
patients with gastroduodenal ulcer is 0.03 year lesser than patients with cancer who do
not have gastroduodenal ulcer however this is not significant p value (0.95) .

DISCUSSION
Research on the association between ulcers and cancer is scarce. The purpose of this
study was to analyze the relationship between ulcer and age of cancer diagnosis as well
as compare the mean age of cancer diagnosis between the ulcer and non-ulcer patients
in our study population.
The results of our analysis suggest that there was no association between
gastroduodenal ulcer diagnosis and age of cancer diagnosis. Our finding differ from
some previous work (Bao et al., 2010), who provided the most direct evidence for ulcer

21

association with pancreas cancer. The study found that gastric ulcer but not duodenal
ulcer increases the risk of pancreas cancer and some possible mechanism suggested is
that the association found might be due to the inflammatory response seen in
Helicobacter pylori infection and the ulcer healing process. Chronic inflammation
generates growth a factor among which is IGF1 which might contribute to the pathology
of pancreas cancer.
Findings from our study also differ from a matched case control study (Lin et al., 2015),
who reported a positive association between peptic ulcer and colorectal cancer
particularly among patients with helicobacter pylori infection thereby, suggesting the role
played by insulin growth factor 1 in ulcer healing and cancer pathogenesis. The
discrepancy between our study (Bao et al., 2010) and (Lin et al., 2015) may be largely
attributed to the small sample size of our study. Data from a large United State cohort
consisting of 51,529 health workers was analyzed (Bao et al., 2010) and data from
60,365 study participants was analyzed (Lin et al., 2015).
An unexpected finding of our study was the mean difference in age of cancer diagnosis
for gastroduodenal ulcer patient was higher (-5.15 years) than that for nongastroduodenal ulcer patient (-6.79 years) when age of cancer diagnosis was
normalized to U.S population. However this difference was not significant (P-Value
0.42). It was also observed that the mean age of cancer diagnosis for patients with
gastroduodenal in the iCaRe2 was also higher than the age of cancer diagnosis for
patient with no gastroduodenal ulcer. This finding was also not significant (p value 0.2).
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The results from this study might have been different if the study had a large enough
sample size.
This study is significant in that it will serve as a landmark for future research which may
lead to establishing the link between ulcers and cancers and thus, predict and or
prevent certain cancer types through early detection of gastroduodenal ulcers.

LIMITATIONS
The study had some limitations. First, the diagnosis of our exposure variable of interest
was based patient self-report of having ulcer. iCaRe2 questionnaire only had a check
box for which patients tick yes for presence of ulcer. In the absence of ulcer there was
no check box hence, we assumed all patients that didn’t tick the check box had no ulcer
there by introducing selection bias. Furthermore, small sample size due to a small
number of patients who responded to the exposure question of interest was a limitation
in this study hence, relationship between covariates and outcome variable was not
studied because it would further reduce our sample size hence crude analysis was
done. Also, we were limited in accessing the possibility that occurrence of
gastroduodenal ulcers preceded the occurrence of cancers because of the limited
number of patients that reported age of ulcer diagnosis. However the few patients that
reported age of ulcer diagnosis, data show diagnosis of cancer preceded diagnosis of
ulcer. Finally, due to unavailability of data, we were limited in exploring the relationship
between the median age of cancer diagnosis of our sample population and the median
age of cancer diagnosis among patients seen in Nebraska.
23

The results from this study suggest no association between gastroduodenal ulcer and
pancreas, head and neck, gastrointestinal and abdominal cancer. The study was
limited by sample size hence, further research with a large sample is needed to
investigate both the association as well as the biologic mechanism that link
gastroduodenal ulcer and cancers.
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